141 related articles for article (PubMed ID: 1694090)
21. Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells.
Yi Q; Dabadghao S; Osterborg A; Bergenbrant S; Holm G
Blood; 1997 Sep; 90(5):1960-7. PubMed ID: 9292530
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.
Pellat-Deceunynck C; Bataille R; Robillard N; Harousseau JL; Rapp MJ; Juge-Morineau N; Wijdenes J; Amiot M
Blood; 1994 Oct; 84(8):2597-603. PubMed ID: 7522634
[TBL] [Abstract][Full Text] [Related]
23. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
[TBL] [Abstract][Full Text] [Related]
24. Depression in caregivers of demented patients is associated with altered immunity: impaired proliferative capacity, increased CD8+, and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+).
Castle S; Wilkins S; Heck E; Tanzy K; Fahey J
Clin Exp Immunol; 1995 Sep; 101(3):487-93. PubMed ID: 7545096
[TBL] [Abstract][Full Text] [Related]
25. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.
Drach J; Gattringer C; Huber H
Clin Exp Immunol; 1991 Mar; 83(3):418-22. PubMed ID: 1706237
[TBL] [Abstract][Full Text] [Related]
26. Natural killer cell activity in monoclonal gammopathies: relation to disease activity.
Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H
Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786
[TBL] [Abstract][Full Text] [Related]
27. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma.
Matsuo Y; Drexler HG; Nishizaki C; Harashima A; Fukuda S; Kozuka T; Sezaki T; Orita K
Br J Haematol; 2000 Apr; 109(1):54-63. PubMed ID: 10848782
[TBL] [Abstract][Full Text] [Related]
28. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen.
Schneider U; van Lessen A; Huhn D; Serke S
Br J Haematol; 1997 Apr; 97(1):56-64. PubMed ID: 9136942
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine markers expressed by human natural killer (NK) cells are also detectable on human small cell carcinomas, neuroblastomas, and sea urchin coelomocytes.
Koros AM
Int J Neurosci; 1990 Apr; 51(3-4):255-6. PubMed ID: 1703997
[No Abstract] [Full Text] [Related]
30. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.
Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM
Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543
[TBL] [Abstract][Full Text] [Related]
31. Lymphoid tissue in the endometrium of women with unexplained infertility: morphometric and immunohistochemical aspects.
Klentzeris LD; Bulmer JN; Warren MA; Morrison L; Li TC; Cooke ID
Hum Reprod; 1994 Apr; 9(4):646-52. PubMed ID: 7519197
[TBL] [Abstract][Full Text] [Related]
32. Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS.
Billadeau D; Greipp P; Ahmann G; Witzig T; Van Ness B
Curr Top Microbiol Immunol; 1995; 194():9-16. PubMed ID: 7895525
[No Abstract] [Full Text] [Related]
33. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.
Funaro A; Spagnoli GC; Ausiello CM; Alessio M; Roggero S; Delia D; Zaccolo M; Malavasi F
J Immunol; 1990 Oct; 145(8):2390-6. PubMed ID: 1976692
[TBL] [Abstract][Full Text] [Related]
34. High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
Adams HC; Stevenaert F; Krejcik J; Van der Borght K; Smets T; Bald J; Abraham Y; Ceulemans H; Chiu C; Vanhoof G; Usmani SZ; Plesner T; Lonial S; Nijhof I; Lokhorst HM; Mutis T; van de Donk NWCJ; Sasser AK; Casneuf T
Cytometry A; 2019 Mar; 95(3):279-289. PubMed ID: 30536810
[TBL] [Abstract][Full Text] [Related]
35. High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma.
Kawano MM; Mahmoud MS; Huang N; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
Br J Haematol; 1995 Dec; 91(4):860-4. PubMed ID: 8547130
[TBL] [Abstract][Full Text] [Related]
36. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
[TBL] [Abstract][Full Text] [Related]
37. [Detection of myeloma cells in the peripheral blood using flow cytometry].
Adam Z; Klabusay M; Vorlícek J; Hájek R
Vnitr Lek; 1997 Sep; 43(9):592-8. PubMed ID: 9750468
[TBL] [Abstract][Full Text] [Related]
38. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis.
Matsuda M; Gono T; Shimojima Y; Hoshii Y; Ikeda S
Amyloid; 2003 Jun; 10(2):110-6. PubMed ID: 12964418
[TBL] [Abstract][Full Text] [Related]
40. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.
Pope B; Brown RD; Gibson J; Petersen A; Wiley J; Joshua DE
Leuk Lymphoma; 1997 Sep; 27(1-2):83-91. PubMed ID: 9373199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
